Predict your next investment

Angel Investor (Individual)
denniscrowley.com

See what CB Insights has to offer

Investments

9

Portfolio Exits

4

About Dennis Crowley

Dennis Crowley is an angel investor and entrepreneur. He is currently co-Founder of Foursquare Labs, a venture capital-backed location based services firm. His prior firm, Dodgeball, was founded in 2000 and subsequently acquired by Google. Dodgeball was similar to Foursquare in that it sought to combine mobile location-based services with people's social circle to help them meet their friends and other people as well as discover new places near them. He has formerly worked with or at Vindigo, MTV Networks, ABC, Jupiter Research and JMXI Liquidating Trust. He holds a graduate degree from New York University (NYU) and received his Bachelor's from Syracuse University.

Dennis Crowley Headquarter Location

New York, New York,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Dennis Crowley News

08:05 ET Corza Medical Announces Dennis Crowley as Executive Vice President, Corporate Development

Jan 4, 2022

Experienced executive represents continued investment in leadership talent to build front-running company in surgical device industry News provided by Share this article Share this article WESTWOOD, Mass., Jan. 4, 2022 /PRNewswire/ -- Corza Medical ("Corza"), a leading global manufacturer of innovative surgical technologies, today announced the expansion of its leadership team with the addition of Dennis Crowley as Executive Vice President, Corporate Development. Mr. Crowley will lead Corza's growth and expansion with responsibility for M&A, licensing and strategic planning. He will report to Dan Croteau, CEO, and Gregory Lucier, Executive Chairman. Mr. Crowley brings nearly thirty years of experience in strategy and business development, driving organic and acquired growth through mergers and acquisitions, joint ventures and strategic affiliations. He has been a leader in over 100 global acquisitions and divestitures. Most recently he served as SVP, Business Development & Licensing at Baxter Healthcare and previously held executive leadership roles at Tyco International and Medtronic/Covidien, among others. "I'm thrilled to welcome Dennis to the Corza Medical team, as his industry experience will be a tremendous asset to the ongoing expansion of the business," said Lucier. "Corza is committed to investing in our leadership talent to identify more growth initiatives and accretive acquisitions that expand the breadth and depth of solutions we bring to customers. We're excited about this next chapter as we continue to bring phenomenal performance, exceptional value and an unparalleled customer service experience to healthcare professionals." "Dennis brings tremendous experience in healthcare business development, with expertise and a proven track record of cultivating relationships, negotiating complex deal structures and building teams to generate growth," said Croteau. Corza Medical's priority has been to build a global business and increase value through strategic M&A activity, which has included the simultaneous acquisition and merger of Surgical Specialties Corporation and the TachoSil® Fibrin Sealant Patch, and the add-on of Katena Products. "Corza Medical is a company with a strong growth trajectory," said Crowley. "I look forward to identifying future medtech/life science platform investments to accelerate the company's success." Mr. Crowley will be based in Corza's Westwood, MA headquarters. He holds a Bachelor's degree from Harvard College. About Corza Medical Corza Medical is a leading global manufacturer of innovative surgical technologies. With a global team of over 1,800 employees supporting clinicians, distributors and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with industry-leading brands, including Quill™ barbed sutures, Sharpoint™ Plus and Look™ surgical sutures, Sharpoint™ ophthalmic knives, and the TachoSil® fibrin sealant patch. For more information, please visit www.corza.com . Media Contact:

Dennis Crowley Investments

9 Investments

Dennis Crowley has made 9 investments. Their latest investment was in Gowalla as part of their Seed VC on January 1, 2021.

CBI Logo

Dennis Crowley Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/28/2021

Seed VC

Gowalla

$4M

Yes

1

4/30/2014

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

4/1/2014

Seed VC

Subscribe to see more

$99M

Subscribe to see more

0

9/18/2013

Series A

Subscribe to see more

$99M

Subscribe to see more

10

7/31/2013

Seed VC

Subscribe to see more

Subscribe to see more

10

Date

1/28/2021

4/30/2014

4/1/2014

9/18/2013

7/31/2013

Round

Seed VC

Seed VC

Seed VC

Series A

Seed VC

Company

Gowalla

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$4M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

0

10

10

Dennis Crowley Portfolio Exits

4 Portfolio Exits

Dennis Crowley has 4 portfolio exits. Their latest portfolio exit was Metamarkets on November 03, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/3/2017

Acquired

3

6/27/2017

Asset Sale

Subscribe to see more

Subscribe to see more

10

11/19/2015

IPO

Subscribe to see more

$99M

Subscribe to see more

10

9/6/2012

Acquired

Subscribe to see more

Subscribe to see more

0

Date

11/3/2017

6/27/2017

11/19/2015

9/6/2012

Exit

Acquired

Asset Sale

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

0

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.